Evaluation of a Capped Dosing Telavancin Regimen Compared to Standard Dosing at a Large Community Teaching Hospital.
Antimicrob Agents Chemother
; 66(1): e0160321, 2022 01 18.
Article
em En
| MEDLINE
| ID: mdl-34662182
ABSTRACT
Telavancin, a lipoglycopeptide antibiotic, is traditionally dosed at 10 mg/kg based on total body weight but is associated with toxicities that limit its use. This study supports the use of a capped dosing regimen of 750 mg in obese patients, which is associated with equal efficacy and fewer adverse effects compared to traditional dosing.
Palavras-chave
Texto completo:
1
Base de dados:
MEDLINE
Assunto principal:
Aminoglicosídeos
/
Antibacterianos
Idioma:
En
Ano de publicação:
2022
Tipo de documento:
Article